Contraindicated (1)pentobarbital will reduce the level or result of naloxegol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Utilization of naloxegol with sturdy CYP3A4 inducers will not be proposedPsychological, tolerance and physical dependence may possibly manifest with continued use; sufferers with psychological depe